Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

12/07/06 Drug that can fight brain cancer discovered        

12/07/06 Consortium of international hospitals receives $11 million to conduct study of genetic brain tumors        

12/07/06 Cell Phones Do Not Cause Cancer?        

12/01/06 Report of the 11th Annual Society for Neuro-oncology - from the International Brain Tumour Alliance        

11/30/06 Brain Tumor Therapy Makes U.S. Debut In Chicago (Video)        

11/30/06 Brain Tumor Resection Live Video - Today        

11/28/06 Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities.        

11/28/06 Fractionated stereotactic radiotherapy using gamma unit after hyperbaric oxygenation on recurrent high-grade gliomas.        

11/28/06 Brain tumor detection campaign begins        

11/28/06 Bradmer Contracts With Prologue Research to Manage Multi-Center Pivotal Trial of Neuradiab in Brain Cancer        

11/28/06 Fine Wine Fundraiser for Brain Tumor Research        

11/28/06 Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy.        

11/28/06 Northwest Biotherapeutics Receives Institutional Review Board Approval to Accrue Patients in Phase II Brain Cancer Trial        

11/26/06 New Christmas book for children to benefit pediatric brain tumor research        

11/22/06 High-resolution Global Genomic Survey of 178 Gliomas Reveals Novel Regions of Copy Number Alteration and Allelic Imbalances.        

11/22/06 Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions.        

11/22/06 Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.        

11/22/06 The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme        

11/22/06 Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme        

---

Displaying Stories 4021 to 4040 of 7673
Previous 20           Next 20